Trump praised ‘natural 7-OH’; DEA moves to ban it
Two months after President Donald Trump said his administration was looking “very seriously” at approving “natural 7-OH,” the Drug Enforcement Administration moved Wednesday to place the substance into Schedule I as a controlled opioid.
7-OH, or 7-hydroxymitragynine, is a psychoactive compound in the kratom plant, sold in gas stations and smoke shops as tablets, gummies and drink mixes.
The designation would subject anyone who makes, distributes or sells 7-OH above the threshold to the same federal criminal, civil and administrative penalties as heroin or LSD – enforcement DEA would carry out for up to two years under existing agency budget and staffing.
Trump made the comment May 11 in the Oval Office during a maternal health event, telling reporters, “We’re looking very seriously at natural 7-OH and getting that approved.”
The notice of intent DEA filed Wednesday would place 7-OH above a specified threshold into Schedule I, including botanical kratom material, not just synthetic products. The threshold covers kratom exceeding 0.050% 7-OH by dry weight, with no exception for natural products.
“7-OH, MP, MGM-15, and MGM-16 are dangerous opioids that fuel addiction and put American lives at risk,” HHS Secretary Robert F. Kennedy Jr. said in a statement. DEA Administrator Terrance Cole said the action targets “highly concentrated, synthetic 7-OH products.”
DEA filed two notices of intent with the Federal Register Wednesday; both publish July 6. HHS opened a public comment period on the threshold through July 31. DEA can issue a final temporary order 30 days after publication, effective for two years.
DEA cited 165 poison control exposure cases involving 7-OH from January through July 2025, with 35% resulting in serious health problems. Nine states have already banned 7-OH outright; four more cap its concentration.
The action follows FDA warning letters to seven companies selling 7-OH products in July 2025 and a December 2025 seizure of about $1 million worth of 7-OH products from three Missouri firms.
Latest News Stories
Feds charge 14 in Ohio fraud schemes, totaling $50M
U.S. Supreme Court rules in favor of generic drug patents
Former HHS secretary tied to company that could benefit from CMS screening proposal
Supreme Court rules against Verizon, AT&T over privacy penalties
Illinois quick hits: Stop child care scams act clears U.S. House, Illinois U.S. Reps introduce immigrant due process bill
Trump to tap Blanche as attorney general
Trump signs executive orders on customs, federal workforce reforms
McCuskey eyes delay, reversal of furnace, water heater rules
Pratt, Bass on track to face each other in Nov. 3 mayoral race
Kiley, Wahab, Desmond hold onto leads in House districts
GOP maintains leads despite congressional redistricting
WATCH: Trump acknowledges Iranian hardliners could jeopardize deal